Cancer Research Trust Fund Act
- Sponsor
- Rep. Hinson, Ashley [R-IA-2]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Aug 13, 2026
Bottom line
The bill creates a new trust fund, potentially financed by imported tobacco duties, to boost cancer research, specifically targeting rare and pediatric cancers.
What it actually does
This bill establishes a dedicated 'Cancer Research Trust Fund' in the U.S. Treasury, to be funded by an authorization of appropriations equal to ten percent of the gross duties collected annually on imported tobacco and tobacco substitute articles. The funds are to be used by the Secretary of Health and Human Services, in coordination with the Secretary of War (acting through the Director of the Defense Health Agency), for critical research and development into early cancer screening, prevention, treatments, and innovative therapies, with a priority on rare cancers and pediatric populations.
Proponents argue
Supporters argue this bill provides a crucial, dedicated funding stream for cancer research, addressing critical gaps, particularly for rare cancers and pediatric populations which may receive less attention from general research funding. They contend that linking the fund to tobacco duties creates a logical connection between a public health concern and its mitigation, ensuring a consistent revenue source for vital scientific advancements.
Opponents contend
Critics might argue that while cancer research is important, creating a new trust fund with an authorized, rather than mandatory, appropriation mechanism does not guarantee funding and adds complexity to federal budgeting. Concerns could also be raised about the long-term stability of a funding source tied to tobacco duties, given potential declines in tobacco use, and the unusual inclusion of the 'Secretary of War' which suggests potential drafting issues.
The bill is very short and straightforward, allowing for a quick and easy understanding of its core provisions.
Section 2(a)
Establishment of Cancer Research Trust Fund
This provision formally creates a new financial account within the U.S. Treasury, to be known as the 'Cancer Research Trust Fund.' This fund is intended to hold money specifically designated for cancer research, separate from the general federal budget, ensuring that appropriated funds are used solely for this purpose.
Supporters argue
Proponents argue that establishing a dedicated trust fund ensures transparency and accountability for cancer research funding, preventing funds from being diverted to other priorities. It signals a strong commitment to this critical area.
Critics contend
No specific opposition is typically raised against the establishment of a trust fund itself, though concerns may arise regarding its funding mechanism or overall necessity compared to existing funding structures.
Tradeoffs
The tradeoff is between creating a focused funding vehicle and potentially adding to the complexity of federal financial management, though this is a common legislative tool.
Section 2(b)
Funding Mechanism for the Trust Fund
This section authorizes Congress to appropriate money to the Cancer Research Trust Fund. The amount authorized is equal to ten percent of the total gross duties collected each fiscal year from imported tobacco and tobacco substitute articles. This means that while a specific revenue source is identified, the actual transfer of funds still requires a separate act of appropriation by Congress.
Section 2(d)
Purposes and Priorities of the Fund
This provision outlines how the money in the Cancer Research Trust Fund is to be used. The Secretary of Health and Human Services (HHS), in coordination with the Secretary of War (through the Director of the Defense Health Agency), must use the funds for critical research and development related to early cancer screening, prevention, treatments, and innovative therapies. A specific priority is given to research on rare cancers and cancers affecting pediatric populations.
The bill states that amounts are 'authorized to be appropriated' to the Fund, rather than directly appropriating or mandating the transfer of funds.
Section 2(b)
Why it matters:This is standard legislative practice for establishing a funding mechanism that still requires annual congressional approval, rather than creating mandatory spending. It maintains congressional control over appropriations.
Case for: Supporters argue this approach allows for ongoing congressional oversight and ensures that funding levels can be adjusted based on current needs and fiscal realities, rather than locking in a fixed amount indefinitely.
Case against: Critics contend that 'authorized to be appropriated' introduces uncertainty, as the fund's actual resources depend on annual legislative battles. This could undermine the goal of providing a stable, predictable funding stream for long-term research projects.
Estimated impact: The actual financial impact on cancer research is entirely dependent on future appropriations acts, which could range from zero to the full authorized amount.
The bill mandates coordination between the Secretary of Health and Human Services and the 'Secretary of War acting through the Director of the Defense Health Agency' for carrying out the purposes of the fund.
Section 2(d)(1)
Why it matters:This is almost certainly a drafting error, as the Department of War no longer exists. If intended, it would be an unusual and potentially confusing attempt to involve military health research, but its inclusion as written is highly anomalous.
Case for: If interpreted as the Secretary of Defense, proponents would argue that involving the Defense Health Agency leverages military medical research capabilities and expertise, potentially accelerating breakthroughs relevant to both civilian and military populations.
Case against: Critics would point to the outdated terminology as a significant drafting flaw, questioning the bill's precision and potentially creating legal or administrative confusion regarding implementation. It could also raise questions about the appropriate scope of military involvement in civilian health research.
Estimated impact: If interpreted as the Secretary of Defense, it would integrate military health research into the fund's activities. If taken literally, it would be unimplementable as written.